You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Positive results for Ipsen’s metastatic pancreatic cancer treatment

Ipsen has announced that the phase 3 NAPOLI 3 trial of Onivyde – a irinotecan liposome injection plus 5 fluorouracil/leucovorin and oxaliplatin – has successfully met its primary endpoint.